Effect of Odanacatib on the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin after Administration in Healthy Postmenopausal Female Subjects.

Trial Profile

Effect of Odanacatib on the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin after Administration in Healthy Postmenopausal Female Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Mar 2013

At a glance

  • Drugs Odanacatib (Primary) ; Warfarin (Primary)
  • Indications Postmenopausal osteoporosis; Thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Mar 2013 New trial record
    • 09 Mar 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
    • 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top